Analysts Set Chemed Corporation (NYSE:CHE) Target Price at $501.50

Chemed Corporation (NYSE:CHE) has earned an average recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $501.50.

A number of research analysts recently commented on the company. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada upped their price objective on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Oppenheimer lowered their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Monetary Solutions Ltd bought a new position in Chemed during the fourth quarter valued at about $25,000. Los Angeles Capital Management LLC bought a new position in Chemed during the fourth quarter valued at about $26,000. Smartleaf Asset Management LLC boosted its stake in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new position in Chemed during the fourth quarter valued at about $27,000. Finally, Global Retirement Partners LLC boosted its stake in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after buying an additional 58 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE opened at $419.07 on Wednesday. The company has a market cap of $5.56 billion, a P/E ratio of 22.84, a PEG ratio of 1.58 and a beta of 0.54. The stock has a fifty day moving average price of $415.27 and a 200 day moving average price of $424.51. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed has a 12 month low of $365.20 and a 12 month high of $562.77.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the business earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts forecast that Chemed will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be paid a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 13.08%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.